HSD17B10 and Alzheimer disease: On the other hand, the enhanced concentrations of 17β-HSD10 in CSF of individuals with AD [10–12] suggest that the moderate average increase in 17β-HSDS10 expression in the brains of Tg models of AD should be expected.